580 related articles for article (PubMed ID: 24899306)
1. Sphingolipid lysosomal storage disorders.
Platt FM
Nature; 2014 Jun; 510(7503):68-75. PubMed ID: 24899306
[TBL] [Abstract][Full Text] [Related]
2. The expanding boundaries of sphingolipid lysosomal storage diseases; insights from Niemann-Pick disease type C.
Platt FM
Biochem Soc Trans; 2023 Oct; 51(5):1777-1787. PubMed ID: 37844193
[TBL] [Abstract][Full Text] [Related]
3. Sphingolipids and neuronal degeneration in lysosomal storage disorders.
Grassi S; Chiricozzi E; Mauri L; Sonnino S; Prinetti A
J Neurochem; 2019 Mar; 148(5):600-611. PubMed ID: 29959861
[TBL] [Abstract][Full Text] [Related]
4. Sphingolipids and lysosomal pathologies.
Schulze H; Sandhoff K
Biochim Biophys Acta; 2014 May; 1841(5):799-810. PubMed ID: 24184515
[TBL] [Abstract][Full Text] [Related]
5. Lyso-glycosphingolipids: presence and consequences.
van Eijk M; Ferraz MJ; Boot RG; Aerts JMFG
Essays Biochem; 2020 Sep; 64(3):565-578. PubMed ID: 32808655
[TBL] [Abstract][Full Text] [Related]
6. Accumulation of sphingolipids in SAP-precursor (prosaposin)-deficient fibroblasts occurs as intralysosomal membrane structures and can be completely reversed by treatment with human SAP-precursor.
Burkhardt JK; Hüttler S; Klein A; Möbius W; Habermann A; Griffiths G; Sandhoff K
Eur J Cell Biol; 1997 May; 73(1):10-8. PubMed ID: 9174667
[TBL] [Abstract][Full Text] [Related]
7. The cell biology of disease: lysosomal storage disorders: the cellular impact of lysosomal dysfunction.
Platt FM; Boland B; van der Spoel AC
J Cell Biol; 2012 Nov; 199(5):723-34. PubMed ID: 23185029
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of pathogenesis in a glycosphingolipid and a glycoprotein storage disease.
d'Azzo A; Bonten E
Biochem Soc Trans; 2010 Dec; 38(6):1453-7. PubMed ID: 21118106
[TBL] [Abstract][Full Text] [Related]
9. Storage solutions: treating lysosomal disorders of the brain.
Jeyakumar M; Dwek RA; Butters TD; Platt FM
Nat Rev Neurosci; 2005 Sep; 6(9):713-25. PubMed ID: 16049428
[TBL] [Abstract][Full Text] [Related]
10. SnapShot: Lysosomal Storage Diseases.
Martina JA; Raben N; Puertollano R
Cell; 2020 Feb; 180(3):602-602.e1. PubMed ID: 32032518
[TBL] [Abstract][Full Text] [Related]
11. Glycosphingolipid lysosomal storage diseases: therapy and pathogenesis.
Jeyakumar M; Butters TD; Dwek RA; Platt FM
Neuropathol Appl Neurobiol; 2002 Oct; 28(5):343-57. PubMed ID: 12366816
[TBL] [Abstract][Full Text] [Related]
12. The Link between Gaucher Disease and Parkinson's Disease Sheds Light on Old and Novel Disorders of Sphingolipid Metabolism.
Indellicato R; Trinchera M
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284408
[TBL] [Abstract][Full Text] [Related]
13. Lysosomal lipid storage diseases.
Schulze H; Sandhoff K
Cold Spring Harb Perspect Biol; 2011 Jun; 3(6):. PubMed ID: 21502308
[TBL] [Abstract][Full Text] [Related]
14. A view on sphingolipids and disease.
Kolter T
Chem Phys Lipids; 2011 Sep; 164(6):590-606. PubMed ID: 21570958
[TBL] [Abstract][Full Text] [Related]
15. Sphingolipid lysosomal storage diseases: from bench to bedside.
Abed Rabbo M; Khodour Y; Kaguni LS; Stiban J
Lipids Health Dis; 2021 May; 20(1):44. PubMed ID: 33941173
[TBL] [Abstract][Full Text] [Related]
16. 19q13.12 microdeletion syndrome fibroblasts display abnormal storage of cholesterol and sphingolipids in the endo-lysosomal system.
Zhao K; van der Spoel A; Castiglioni C; Gale S; Fujiwara H; Ory DS; Ridgway ND
Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2108-2118. PubMed ID: 29580926
[TBL] [Abstract][Full Text] [Related]
17. Characterization of
Sellin J; Schulze H; Paradis M; Gosejacob D; Papan C; Shevchenko A; Psathaki OE; Paululat A; Thielisch M; Sandhoff K; Hoch M
Dis Model Mech; 2017 Jun; 10(6):737-750. PubMed ID: 28389479
[TBL] [Abstract][Full Text] [Related]
18. Secondary lipid accumulation in lysosomal disease.
Walkley SU; Vanier MT
Biochim Biophys Acta; 2009 Apr; 1793(4):726-36. PubMed ID: 19111580
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of Secondary Ganglioside and Lipid Accumulation in Lysosomal Disease.
Breiden B; Sandhoff K
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32272755
[TBL] [Abstract][Full Text] [Related]
20. Neuronal Ganglioside and Glycosphingolipid (GSL) Metabolism and Disease : Cascades of Secondary Metabolic Errors Can Generate Complex Pathologies (in LSDs).
Sandhoff R; Sandhoff K
Adv Neurobiol; 2023; 29():333-390. PubMed ID: 36255681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
